PARNATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Parnate, and what generic alternatives are available?
Parnate is a drug marketed by Concordia and is included in one NDA.
The generic ingredient in PARNATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Parnate
A generic version of PARNATE was approved as tranylcypromine sulfate by STRIDES PHARMA on June 29th, 2006.
Summary for PARNATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Clinical Trials: | 6 |
Patent Applications: | 4,207 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PARNATE |
What excipients (inactive ingredients) are in PARNATE? | PARNATE excipients list |
DailyMed Link: | PARNATE at DailyMed |
Recent Clinical Trials for PARNATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Central Michigan University | N/A |
Sheppard Pratt Health System | N/A |
National Institute of Mental Health (NIMH) | Phase 4 |
Pharmacology for PARNATE
Drug Class | Monoamine Oxidase Inhibitor |
Mechanism of Action | Monoamine Oxidase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PARNATE
US Patents and Regulatory Information for PARNATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concordia | PARNATE | tranylcypromine sulfate | TABLET;ORAL | 012342-003 | Aug 16, 1985 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |